Table 6.
Hazard Ratio | 95% Confidence Intervals of Hazard Ratio | P‐Value | |
---|---|---|---|
Change in LVIDDN model (n = 327) | |||
Treatment (pimobendan) | 0.64 | 0.46–0.90 | 0.010 |
LVIDDN (per 0.1 unit) | 1.30 | 1.20–1.41 | <0.0001 |
Δ LVIDDN (per 0.1 unit change) | 1.26 | 1.11–1.43 | 0.0003 |
Change in LA/Ao model (n = 329) | |||
Treatment (pimobendan) | 0.63 | 0.46–0.88 | 0.0060 |
LA/Ao (per 0.1 unit) | 1.21 | 1.15–1.28 | <0.0001 |
Δ LA/Ao (per 0.1 unit change) | 1.14 | 1.06–1.22 | 0.0002 |
Change in LVIDSN model (n = 327) | |||
Treatment (pimobendan) | 0.71 | 0.51–1.00 | 0.051 |
LVIDSN (per 0.1 unit) | 1.07 | 0.97–1.18 | 0.16 |
Δ LVIDSN (per 0.1 unit change) | 1.22 | 1.05–1.41 | 0.0084 |
Change in FS% model (n = 329) | |||
Treatment (pimobendan) | 0.64 | 0.46–0.90 | 0.011 |
FS % (per 10 units) | 1.47 | 1.16–1.85 | 0.0014 |
Δ FS% (per 10 units change) | 1.05 | 0.77–1.44 | 0.75 |
Δ, Change in; FS%, fractional shortening; LA/Ao, left atrial‐to‐aortic root ratio; LVIDDN, normalized left ventricular internal diameter in diastole; LVIDSN, normalized left ventricular internal diameter in systole.
All P‐values that appear in bold are < 0.05.